Hope for Depression Research Foundation Launches Precision Psychiatry Initiative
News related to:Hope for Depression Research Foundation · 1 min read
NEW YORK, Nov. 11, 2026 /CourierPR/ -- The Hope for Depression Research Foundation (HDRF) announced its Precision Psychiatry Initiative at its 20th Anniversary HOPE Luncheon at The Plaza Hotel in New York City, on November 10, 2026. This marks a pivotal transition from two decades of foundational research into the underlying mechanisms of depression toward first-in-human studies expected to begin as early as 2027.
Over the past 20 years, HDRF's Depression Task Force (DTF) has investigated approximately 1,500 genes potentially implicated in depression and identified 20 promising therapeutic targets for further study. This integrated, collaborative research engine now informs a growing clinical program investigating biological mechanisms that could lead to more effective and personalized treatments.
HDRF aims to provide strategic partners with human-validated targets, biomarkers, and data to support later-stage clinical development.
The Foundation's Clinical Trial/Drug Discovery Program is designed to bridge the gap between laboratory discoveries and clinical development, supporting early human studies that can help determine whether promising mechanisms merit further investigation. These efforts include research at Mount Sinai, Columbia University, Weill Cornell Medicine, and the Max Planck Institute in Germany.
The HOPE Luncheon featured a keynote by Dr. Manji, who also presented research on brain circuitry and antidepressant treatment. DTF members in attendance included Eric Nestler, M.D., Ph.D.; Conor Liston, M.D., Ph.D.; Helen S. Mayberg, M.D.; René Hen, Ph.D.; and Jonathan Javitch, M.D., Ph.D.
HDRF also recognized Grammy and Academy Award-winning artist Melissa Etheridge with the HOPE Award for Mental Health Advocacy, honored the Founders Group for its Clinical Trial/Drug Discovery Program, and presented Definium Therapeutics with the HOPE Corporate Visionary Award.
Founded in 2006 by Audrey Gruss in memory of her mother, Hope, HDRF funds neuroscience research into the origins, diagnosis, treatment, and prevention of depression. Its Depression Task Force brings together leading scientists from nine institutions working collaboratively on a shared research roadmap.